Data as of Q4 2025 (Dec 31, 2025)

ORACLE INVESTMENT MANAGEMENT INC

โ€ขCIK: 1012622โ€ขFiling: Q4 2025

**ORACLE INVESTMENT MANAGEMENT INC** manages $168M across a portfolio of 22 positions. The fund exhibits a significant concentration in WGS, representing $115.1M of its total assets. Notable secondary allocations include ARDX at $10.9M, followed by MS-PL at $8.7M. This structure suggests a concentrated, high-conviction approach to generating alpha.

Total AUM
$152.6M
+ $11.3M in options
QoQ Performance
+6.5%
Positions
17
+ 4 options
Top 10 Concentration
95.7%
Latest Filing
Q4 2025

Top Holdings Allocation

WGS
ARDX
BHVN
WGS70.2%
ARDX6.7%
BHVN5.3%
TELADOC2.8%
ARDELYX2.1%
QDEL2.1%
FORA1.8%
PSNL1.6%

๐Ÿ“ˆ Biggest Buys

ARDX
ARDELYX INC
+24.5%
6.7% of portfolio
TSHA
TAYSHA GENE THERAPIES INC
NEW
0.9% of portfolio
โ€”CALL
TELADOC HEALTH INC
+38.2%
2.8% of portfolio
EWTX
EDGEWISE THERAPEUTICS INC
NEW
0.6% of portfolio
DAWN
DAY ONE BIOPHARMACEUTICALS I
NEW
0.6% of portfolio

๐Ÿ“‰ Biggest Sells

TDOC
TELADOC HEALTH INC
-49.8%
1.5% of portfolio
WGS
GENEDX HOLDINGS CORP
-0.6%
70.2% of portfolio
โ€”CALL
BIOHAVEN LTD
-15.3%
1.6% of portfolio
โ€”CALL
ARDELYX INC
-5.2%
2.1% of portfolio

Sector Breakdown

Other99.4%
Healthcare0.4%
Consumer0.2%

๐Ÿšช Exited Positionssold since Q3 2025

โ€”
NOVAVAX INC
SOLD
$5.5M
PLTR
PALANTIR TECHNOLOGIES INC
SOLD
$5.4M
CNC
CENTENE CORP DEL
SOLD
$3.9M
NVV1
NOVAVAX INC
SOLD
$2.1M
KOID
KRANESHARES TRUST
SOLD
$718.6K
+1 more exited positions

Changes from Q3 2025

NEW7 new positions
โ†‘5 increased
โ†“4 decreased

Historical Filings

Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023